Literature DB >> 27804926

Estimation of internal organ motion-induced variance in radiation dose in non-gated radiotherapy.

Sumin Zhou1, Xiaofeng Zhu, Mutian Zhang, Dandan Zheng, Yu Lei, Sicong Li, Nathan Bennion, Vivek Verma, Weining Zhen, Charles Enke.   

Abstract

In the delivery of non-gated radiotherapy (RT), owing to intra-fraction organ motion, a certain degree of RT dose uncertainty is present. Herein, we propose a novel mathematical algorithm to estimate the mean and variance of RT dose that is delivered without gating. These parameters are specific to individual internal organ motion, dependent on individual treatment plans, and relevant to the RT delivery process. This algorithm uses images from a patient's 4D simulation study to model the actual patient internal organ motion during RT delivery. All necessary dose rate calculations are performed in fixed patient internal organ motion states. The analytical and deterministic formulae of mean and variance in dose from non-gated RT were derived directly via statistical averaging of the calculated dose rate over possible random internal organ motion initial phases, and did not require constructing relevant histograms. All results are expressed in dose rate Fourier transform coefficients for computational efficiency. Exact solutions are provided to simplified, yet still clinically relevant, cases. Results from a volumetric-modulated arc therapy (VMAT) patient case are also presented. The results obtained from our mathematical algorithm can aid clinical decisions by providing information regarding both mean and variance of radiation dose to non-gated patients prior to RT delivery.

Entities:  

Mesh:

Year:  2016        PMID: 27804926     DOI: 10.1088/0031-9155/61/23/8157

Source DB:  PubMed          Journal:  Phys Med Biol        ISSN: 0031-9155            Impact factor:   3.609


  7 in total

1.  Hybrid volumetric modulated arc therapy for whole breast irradiation: a dosimetric comparison of different arc designs.

Authors:  Velayudham Ramasubramanian; Karunakaran Balaji; Sitaraman Balaji Subramanian; Krishnamoorthi Sathiya; Moorthi Thirunavukarasu; Chandrasekaran Anu Radha
Journal:  Radiol Med       Date:  2019-01-30       Impact factor: 3.469

2.  Hybrid planning techniques for hypofractionated whole-breast irradiation using flattening filter-free beams.

Authors:  Karunakaran Balaji; Sitaraman Balaji Subramanian; Krishnamoorthi Sathiya; Moorthi Thirunavukarasu; Chandrasekaran Anu Radha; Velayudham Ramasubramanian
Journal:  Strahlenther Onkol       Date:  2019-12-20       Impact factor: 3.621

3.  Hybrid volumetric modulated arc therapy for hypofractionated radiotherapy of breast cancer: a treatment planning study.

Authors:  Alexander Venjakob; Michael Oertel; Dominik Alexander Hering; Christos Moustakis; Uwe Haverkamp; Hans Theodor Eich
Journal:  Strahlenther Onkol       Date:  2020-10-17       Impact factor: 3.621

4.  A comprehensive dosimetric study on switching from a Type-B to a Type-C dose algorithm for modern lung SBRT.

Authors:  Christina Zhou; Nathan Bennion; Rongtao Ma; Xiaoying Liang; Shuo Wang; Kristina Zvolanek; Megan Hyun; Xiaobo Li; Sumin Zhou; Weining Zhen; Chi Lin; Andrew Wahl; Dandan Zheng
Journal:  Radiat Oncol       Date:  2017-05-05       Impact factor: 3.481

5.  The Feasibility Study of a Hybrid Coplanar Arc Technique Versus Hybrid Intensity-modulated Radiotherapy in Treatment of Early-stage Left-sided Breast Cancer with Simultaneous-integrated Boost.

Authors:  Yuan-Gui Chen; An-Chuan Li; Wen-Yao Li; Miao-Yun Huang; Xiao-Bo Li; Ming-Qiu Chen; Mutian Zhang; Ben-Hua Xu
Journal:  J Med Phys       Date:  2017 Jan-Mar

6.  Hypofractionated Hybrid Radiotherapy Techniques for Synchronous Bilateral Breast Cancer.

Authors:  Karunakaran Balaji; Velayudham Ramasubramanian
Journal:  Asian Pac J Cancer Prev       Date:  2021-12-01

7.  Does intensity modulation increase target dose calculation errors of conventional algorithms for lung SBRT?

Authors:  Dandan Zheng; Vivek Verma; Shuo Wang; Xiaoying Liang; Sumin Zhou
Journal:  J Appl Clin Med Phys       Date:  2018-02-01       Impact factor: 2.102

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.